More Mastectomies: Is This What Patients Really Want?

Journal of Clinical Oncology

Volumn 27, Issue 25, 2009, Pages 4038-4040

  Morrow, Monica ^a   Harris, Jay R ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 ONCOGENE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; EDITORIAL; FEMALE; GENE MUTATION; HUMAN; MAMMOGRAPHY; MASTECTOMY; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PATIENT SATISFACTION; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT OUTCOME; BREAST TUMOR; NOTE; PATHOLOGY; PATIENT SELECTION; PREDICTION AND FORECASTING; PREOPERATIVE CARE; SEGMENTAL MASTECTOMY; TIME;

BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; PATIENT SATISFACTION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; TIME FACTORS;

EID: 70249087736     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.0078     Document Type: Editorial

References (19)

1. NIH consensus conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
2. Du X, Freeman DH Jr, Syblik DA: What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Res Treat 62:71-79, 2000
3. Lazovich D, Solomon CC, Thomas DB, et al: Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628-637, 1999
4. Ganz P, Kwan L, Stanton AL, et al: Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376-387, 2004
5. Nguyen PL, Taghian AG, Katz MS, et al: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373-2378, 2008
6. Wapnir IL, Anderson SJ, Mamounas EP, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028-2037, 2006
7. Katipamula R, Degnim AC, Hoskin T, et al: Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082-4088, 2009
8. McGuire KP, Santillan A, Kaur P, et al: Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy vs. breast conservation in 5865 patients. Ann Surg Oncol 16:24, 2009 (suppl 1)
9. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007
10. Houssami N, Ciatto S, Macaskill P, et al: Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248-3258, 2008
11. Lehman CD, Gatsonis C, Kuhl CK, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303, 2007
12. Solin LJ, Orel SG, Hwang WT, et al: Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26:386-391, 2008
13. Bleicher RJ, Ciocca RM, Egleston BL, et al: The influence of routine pretreatment MRI on time to treatment, mastectomy rate and positive margins. J Am Coll Surg, in press
14. Pengel KE, Loo CE, Teertstra HJ, et al: The impact of preoperative MRI on breast-conserving surgery of invasive cancer: A comparative cohort study. Breast Cancer Res Treat [epub ahead of print on September 21, 2008]
15. Berg WA, Gutierrez L, NessAiver MS, et al: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830-849, 2004
16. Drew P, Turnbull L, Harvey I, et al: MR imaging in breast cancer: Results of the COMICE trial. Eur J Surg Oncol 34:1156-1156, 2008
17. Turnbull L, Drew P, Walker L, et al: The UK NIHR multicentre randomised COMICE trial of MRI planning for breast conserving treatment for breast cancer. 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008 (abstr 51)
18. Katz SJ, Lantz PM, Janz NK, et al: Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 23:5526-5433, 2005
19. Kyndi M, Sørensen FB, Knudsen H, et al: Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol 26:1419-1426, 2008